Cite
APA Citation
Strik, A., van de Vrie, W., Bloemsaat-Minekus, J., Nurmohamed, M., Bossuyt, P., Bodelier, A., Rispens, T., van Megen, Y., & D'Haens, G. (n.d.). p724 Unchanged infliximab serum concentrations after switching from the originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease: Results from a prospective study (SECURE). Journal of Crohn's and colitis, 12, S477–S478. http://access.bl.uk/ark:/81055/vdc_100095499002.0x000011